Education
About Us
Working with TipRanks
Follow Us
ASP Isotopes, Inc. (ASPI)
NASDAQ:ASPI
RESEARCH TOOLSreports
ASPI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.86 - $9.33
Previous Close$4.79
Volume1.39M
Average Volume (3M)1.91M
Market Cap
$375.47M
Enterprise Value$299.30M
Total Cash (Recent Filing)$2.95M
Total Debt (Recent Filing)$926.60K
Price to Earnings (P/E)―
Beta2.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding72,068,060
10 Day Avg. Volume2,224,449
30 Day Avg. Volume1,913,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.80
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.15K
Enterprise Value/Ebitda-11.97
Forecast
1Y Price Target
$8.50Price Target Upside63.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
ASP Isotopes, Inc. News
PremiumCompany Announcements
ASP Isotopes’ Earnings Call: Milestones and Challenges
PremiumCompany Announcements
ASP Isotopes Inc. Reports 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Commercialization EffortsASP management gave a positive update on its commercialization efforts and enrichment factors.
PartnershipsASP Isotopes enters into term sheet negotiations with Bill Gates backed TerraPower.
Technological ValidationRecent success enriching ytterbium-176 using quantum enrichment validates technological mechanics and increases conviction that ASP Isotopes can successfully enrich HALEU to meet the advanced nuclear fuel opportunity.
Bears Say
Commercial Scale ChallengesRisks include reaching commercial scale after successful lab trials and political risks in South Africa.
Political RisksRisks continue to lie ahead, including reaching commercial scale after successful lab trials, South Africa’s political risk, the possibility of unforeseen curtailments around the proliferation of enrichment technologies, approval/permitting timelines, and the nuclear regulatory commission (NRC) approval of reactors from potential HALEU customers.
Regulatory ApprovalsThe possibility of unforeseen curtailments around the proliferation of enrichment technologies, approval/permitting timelines, and the nuclear regulatory commission (NRC) approval of reactors from potential HALEU customers pose significant risks.
---
Ownership Overview
27.73% Insiders
6.09% Mutual Funds
16.90% Other Institutional Investors
40.49% Public Companies and
Individual Investors
ASPI FAQ
What was ASP Isotopes, Inc.’s price range in the past 12 months?
ASP Isotopes, Inc. lowest stock price was $1.86 and its highest was $9.33 in the past 12 months.
What is ASP Isotopes, Inc.’s market cap?
ASP Isotopes, Inc.’s market cap is $375.47M.
When is ASP Isotopes, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ASP Isotopes, Inc.’s earnings last quarter?
ASP Isotopes, Inc. released its earnings results on Mar 31, 2025. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.03.
Is ASP Isotopes, Inc. overvalued?
According to Wall Street analysts ASP Isotopes, Inc.’s price is currently Undervalued.
Does ASP Isotopes, Inc. pay dividends?
ASP Isotopes, Inc. does not currently pay dividends.
What is ASP Isotopes, Inc.’s EPS estimate?
ASP Isotopes, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ASP Isotopes, Inc. have?
ASP Isotopes, Inc. has 72,068,060 shares outstanding.
What happened to ASP Isotopes, Inc.’s price movement after its last earnings report?
ASP Isotopes, Inc. reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went up 12.201%.
Which hedge fund is a major shareholder of ASP Isotopes, Inc.?
Currently, no hedge funds are holding shares in ASPI
---
ASP Isotopes, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (63.15% Upside)
$8.50 (63.15% Upside)
Blogger Sentiment
Bullish
ASPI Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Positive
Last 7 Days ▼ 2.3%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.45%
12-Months-Change
Fundamentals
Return on Equity
-100.74%
Trailing 12-Months
Asset Growth
231.56%
Trailing 12-Months
Company Description
ASP Isotopes, Inc.
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
---
ASPI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, such as successful enrichment of Ytterbium-176, growth in Pet Labs, and strong cash reserves. However, these were tempered by operational challenges, regulatory delays, and a high short interest in the stock, creating a balanced outlook.Read More>---
ASPI Stock 12 Month Forecast
Average Price Target
$8.50
▲(63.15% Upside)
Technical Analysis
---